Quote:
Originally Posted by Trapper John
Phase I, II and III are always conducted in humans. The difference in the case of vaccines is the size (#of test subjects) and complexity (# and type of cohorts, and #of test locations).
This is why I, as a small, private drug developer, would never, never embark down the path of vaccine development. The economics, risk/reward just don't work for a small company!
Oh, and to your question about the speed of development re: the mumps vaccine. The shortened development timeline was due entirely to the development of the antigen by using the newly developed mRNA technology rather than using killed virus or developing an inactivated variant. None of the safety/efficacy studies were abbreviated or altered in any way to shorten the Covid vaccine approval.
|
I apologize. I do not know anything about how the testing is done. I have always presumed that all measures were taken to make sure a vaccine does not endanger the subject it is given to.
If as you say none of the safety/efficacy studies were abbreviated or altered, then how is that there have been, as of October 8th, 16,766 deaths reported from the Covid vaccines?
The below graph depicts all deaths associated since 1990 when the Vaccine Adverse Events Reporting System (VAERS) was started. I'm seeing something wrong if none of the safety/efficacy studies were abbreviated or altered, when compared to all the previous developed vaccines.
vaccine deaths by year.jpg
Data from VAERS can be found at
www.openvaers.com or vaers.hhs.gov
Threaded Mode
